Tough question - they WILL get a bump up as they get closer to FDA approval. They are in trouble, though, with incredible high cash burn and will need financing as well. I do think they will get some market share, perhaps 1%, but I don't think it will really go any further than that. Being 2nd to market will get some units sold.
Again, I would continue to watch and see how things develop but with Titan - there is a better oppty IMO IF they simply get their act together.
4/30 to prove it to me or a likely 500 Index fund.
News 
Market Data 
Discover 
